Quality of life in functional movement disorders is as altered as in organic movement disorders.

Dystonia Functional (psychogenic) movement disorders Parkinson's disease Psychiatric comorbidities Quality of life

Journal

Journal of psychosomatic research
ISSN: 1879-1360
Titre abrégé: J Psychosom Res
Pays: England
ID NLM: 0376333

Informations de publication

Date de publication:
01 2019
Historique:
received: 30 06 2018
revised: 15 10 2018
accepted: 10 11 2018
entrez: 19 1 2019
pubmed: 19 1 2019
medline: 3 3 2020
Statut: ppublish

Résumé

Patients with functional movement disorders (FMD) often report a disability and psychiatric comorbidities. However, few studies have compared these aspects in FMD and in organic movement disorders (OMD). The objectives were to compare QoL and psychiatric comorbidities of FMD and OMD patients. Twenty-one and 30 FMD patients were compared to 21 and 30 sex- and age-matched dystonia and Parkinson patients respectively. QoL was assessed using the Parkinson's Disease Summary Index (PDSI). Psychiatric comorbidities were screened with the Mini International Neuropsychiatric Interview, the Hospital Anxiety and Depression Scale and the Composite International Diagnostic Interview questionnaire. QoL was more altered in FMD than in dystonia on PDSI (42.1 vs 25.1; p = .003). No significant difference was observed in QoL in FMD and Parkinson's disease on PDSI (38.3 vs 32.2; p = .61). Moreover, FMD patients were more often unemployed because of their condition than dystonia (61.9% vs 14.3%; p = .01) and Parkinson patients (53.3% vs 13.3%; p = .005). The occurrence of anxiety (p = .58 and > 0.99), depression (p = .77 and 0.77), and traumatic events (p = .58 and 0.75) was not different between groups. FMD patients reported more often sexual abuse than dystonia (28,6% vs 4.8%; p = .13) and Parkinson patients (23.3% vs 0.0%; p = .02). FMD patients presented a significant alteration of QoL and no increased psychiatric comorbidities compared to OMD patients. These results highlight the impact of FMD and suggest that neurologists should be as involved in the management of FMD as they are in OMD.

Identifiants

pubmed: 30654984
pii: S0022-3999(18)30657-3
doi: 10.1016/j.jpsychores.2018.11.006
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10-16

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Thierry Gendre (T)

Department of Neurology, Henri Mondor University Hospital, AP-HP, Créteil, France; Department of Neurology, Movement Disorders Unit, Pitié-Salpêtrière University Hospital, AP-HP, Paris, France. Electronic address: thierry.gendre@aphp.fr.

Guilhem Carle (G)

Department of Neurology, Movement Disorders Unit, Pitié-Salpêtrière University Hospital, AP-HP, Paris, France; Brain and Spine Institute, UPMC UMRS 1127, INSERM U1127, CNRS UMR 7225, Paris, France.

Francine Mesrati (F)

Department of Neurophysiology, Pitié-Salpêtrière University Hospital, AP-HP, Paris, France.

Cécile Hubsch (C)

Department of Neurology, Movement Disorders Unit, Pitié-Salpêtrière University Hospital, AP-HP, Paris, France.

Thomas Mauras (T)

Department of Neurology, Movement Disorders Unit, Pitié-Salpêtrière University Hospital, AP-HP, Paris, France.

Emmanuel Roze (E)

Department of Neurology, Movement Disorders Unit, Pitié-Salpêtrière University Hospital, AP-HP, Paris, France; Brain and Spine Institute, UPMC UMRS 1127, INSERM U1127, CNRS UMR 7225, Paris, France.

Marion Houot (M)

Sorbonne University, GRC n°21, Alzheimer Precision Medicine (APM), Pitié-Salpêtrière University Hospital, AP-HP, Paris, France.

Bertrand Degos (B)

Centre for Interdisciplinary Research in Biology, Collège de France, INSERM U1050, CNRS UMR7241, Labex Memolife, Paris Sciences et Lettres, Paris, France; Department of Neurology, Avicenne University Hospital, Paris - Seine Saint-Denis University Hospitals, Bobigny, France.

Béatrice Garcin (B)

Brain and Spine Institute, UPMC UMRS 1127, INSERM U1127, CNRS UMR 7225, Paris, France; Department of Neurology, Avicenne University Hospital, Paris - Seine Saint-Denis University Hospitals, Bobigny, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH